1 Study Coverage 1.1 Aminoglycosides Antibiotics Product Introduction 1.2 Market by Type 1.2.1 Global Aminoglycosides Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Neomycin 1.2.3 Tobramycin 1.2.4 Gentamicin 1.2.5 Amikacin 1.2.6 Etimicin 1.2.7 Others 1.3 Market by Application 1.3.1 Global Aminoglycosides Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Post Care Facility 1.3.5 Government & Military 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Aminoglycosides Antibiotics Sales Estimates and Forecasts 2017-2028 2.2 Global Aminoglycosides Antibiotics Revenue Estimates and Forecasts 2017-2028 2.3 Global Aminoglycosides Antibiotics Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Aminoglycosides Antibiotics Sales by Region 2.4.1 Global Aminoglycosides Antibiotics Sales by Region (2017-2022) 2.4.2 Global Sales Aminoglycosides Antibiotics by Region (2023-2028) 2.5 Global Aminoglycosides Antibiotics Revenue by Region 2.5.1 Global Aminoglycosides Antibiotics Revenue by Region (2017-2022) 2.5.2 Global Aminoglycosides Antibiotics Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Aminoglycosides Antibiotics Sales by Manufacturers 3.1.1 Global Top Aminoglycosides Antibiotics Manufacturers by Sales (2017-2022) 3.1.2 Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aminoglycosides Antibiotics in 2021 3.2 Global Aminoglycosides Antibiotics Revenue by Manufacturers 3.2.1 Global Aminoglycosides Antibiotics Revenue by Manufacturers (2017-2022) 3.2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Aminoglycosides Antibiotics Revenue in 2021 3.3 Global Aminoglycosides Antibiotics Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Aminoglycosides Antibiotics Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Aminoglycosides Antibiotics Sales by Type 4.1.1 Global Aminoglycosides Antibiotics Historical Sales by Type (2017-2022) 4.1.2 Global Aminoglycosides Antibiotics Forecasted Sales by Type (2023-2028) 4.1.3 Global Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) 4.2 Global Aminoglycosides Antibiotics Revenue by Type 4.2.1 Global Aminoglycosides Antibiotics Historical Revenue by Type (2017-2022) 4.2.2 Global Aminoglycosides Antibiotics Forecasted Revenue by Type (2023-2028) 4.2.3 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) 4.3 Global Aminoglycosides Antibiotics Price by Type 4.3.1 Global Aminoglycosides Antibiotics Price by Type (2017-2022) 4.3.2 Global Aminoglycosides Antibiotics Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Aminoglycosides Antibiotics Sales by Application 5.1.1 Global Aminoglycosides Antibiotics Historical Sales by Application (2017-2022) 5.1.2 Global Aminoglycosides Antibiotics Forecasted Sales by Application (2023-2028) 5.1.3 Global Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) 5.2 Global Aminoglycosides Antibiotics Revenue by Application 5.2.1 Global Aminoglycosides Antibiotics Historical Revenue by Application (2017-2022) 5.2.2 Global Aminoglycosides Antibiotics Forecasted Revenue by Application (2023-2028) 5.2.3 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) 5.3 Global Aminoglycosides Antibiotics Price by Application 5.3.1 Global Aminoglycosides Antibiotics Price by Application (2017-2022) 5.3.2 Global Aminoglycosides Antibiotics Price Forecast by Application (2023-2028) 6 North America 6.1 North America Aminoglycosides Antibiotics Market Size by Type 6.1.1 North America Aminoglycosides Antibiotics Sales by Type (2017-2028) 6.1.2 North America Aminoglycosides Antibiotics Revenue by Type (2017-2028) 6.2 North America Aminoglycosides Antibiotics Market Size by Application 6.2.1 North America Aminoglycosides Antibiotics Sales by Application (2017-2028) 6.2.2 North America Aminoglycosides Antibiotics Revenue by Application (2017-2028) 6.3 North America Aminoglycosides Antibiotics Market Size by Country 6.3.1 North America Aminoglycosides Antibiotics Sales by Country (2017-2028) 6.3.2 North America Aminoglycosides Antibiotics Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Aminoglycosides Antibiotics Market Size by Type 7.1.1 Europe Aminoglycosides Antibiotics Sales by Type (2017-2028) 7.1.2 Europe Aminoglycosides Antibiotics Revenue by Type (2017-2028) 7.2 Europe Aminoglycosides Antibiotics Market Size by Application 7.2.1 Europe Aminoglycosides Antibiotics Sales by Application (2017-2028) 7.2.2 Europe Aminoglycosides Antibiotics Revenue by Application (2017-2028) 7.3 Europe Aminoglycosides Antibiotics Market Size by Country 7.3.1 Europe Aminoglycosides Antibiotics Sales by Country (2017-2028) 7.3.2 Europe Aminoglycosides Antibiotics Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Aminoglycosides Antibiotics Market Size by Type 8.1.1 Asia Pacific Aminoglycosides Antibiotics Sales by Type (2017-2028) 8.1.2 Asia Pacific Aminoglycosides Antibiotics Revenue by Type (2017-2028) 8.2 Asia Pacific Aminoglycosides Antibiotics Market Size by Application 8.2.1 Asia Pacific Aminoglycosides Antibiotics Sales by Application (2017-2028) 8.2.2 Asia Pacific Aminoglycosides Antibiotics Revenue by Application (2017-2028) 8.3 Asia Pacific Aminoglycosides Antibiotics Market Size by Region 8.3.1 Asia Pacific Aminoglycosides Antibiotics Sales by Region (2017-2028) 8.3.2 Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Aminoglycosides Antibiotics Market Size by Type 9.1.1 Latin America Aminoglycosides Antibiotics Sales by Type (2017-2028) 9.1.2 Latin America Aminoglycosides Antibiotics Revenue by Type (2017-2028) 9.2 Latin America Aminoglycosides Antibiotics Market Size by Application 9.2.1 Latin America Aminoglycosides Antibiotics Sales by Application (2017-2028) 9.2.2 Latin America Aminoglycosides Antibiotics Revenue by Application (2017-2028) 9.3 Latin America Aminoglycosides Antibiotics Market Size by Country 9.3.1 Latin America Aminoglycosides Antibiotics Sales by Country (2017-2028) 9.3.2 Latin America Aminoglycosides Antibiotics Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Aminoglycosides Antibiotics Market Size by Type 10.1.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2017-2028) 10.1.2 Middle East and Africa Aminoglycosides Antibiotics Revenue by Type (2017-2028) 10.2 Middle East and Africa Aminoglycosides Antibiotics Market Size by Application 10.2.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2017-2028) 10.2.2 Middle East and Africa Aminoglycosides Antibiotics Revenue by Application (2017-2028) 10.3 Middle East and Africa Aminoglycosides Antibiotics Market Size by Country 10.3.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2017-2028) 10.3.2 Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Jemicare 11.1.1 Jemicare Corporation Information 11.1.2 Jemicare Overview 11.1.3 Jemicare Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Jemicare Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Jemicare Recent Developments 11.2 Teva 11.2.1 Teva Corporation Information 11.2.2 Teva Overview 11.2.3 Teva Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Teva Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Teva Recent Developments 11.3 Novartis 11.3.1 Novartis Corporation Information 11.3.2 Novartis Overview 11.3.3 Novartis Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Novartis Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Novartis Recent Developments 11.4 Fangyuan-pharma 11.4.1 Fangyuan-pharma Corporation Information 11.4.2 Fangyuan-pharma Overview 11.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Fangyuan-pharma Recent Developments 11.5 Aike Pharmaceutical 11.5.1 Aike Pharmaceutical Corporation Information 11.5.2 Aike Pharmaceutical Overview 11.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Aike Pharmaceutical Recent Developments 11.6 Cipla 11.6.1 Cipla Corporation Information 11.6.2 Cipla Overview 11.6.3 Cipla Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Cipla Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Cipla Recent Developments 11.7 Pfizer 11.7.1 Pfizer Corporation Information 11.7.2 Pfizer Overview 11.7.3 Pfizer Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Pfizer Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Pfizer Recent Developments 11.8 Fresenius Kabi 11.8.1 Fresenius Kabi Corporation Information 11.8.2 Fresenius Kabi Overview 11.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Fresenius Kabi Recent Developments 11.9 Sun Pharma 11.9.1 Sun Pharma Corporation Information 11.9.2 Sun Pharma Overview 11.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Sun Pharma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Sun Pharma Recent Developments 11.10 Hikma 11.10.1 Hikma Corporation Information 11.10.2 Hikma Overview 11.10.3 Hikma Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Hikma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Hikma Recent Developments 11.11 Lannett Company 11.11.1 Lannett Company Corporation Information 11.11.2 Lannett Company Overview 11.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Lannett Company Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Lannett Company Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Aminoglycosides Antibiotics Industry Chain Analysis 12.2 Aminoglycosides Antibiotics Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Aminoglycosides Antibiotics Production Mode & Process 12.4 Aminoglycosides Antibiotics Sales and Marketing 12.4.1 Aminoglycosides Antibiotics Sales Channels 12.4.2 Aminoglycosides Antibiotics Distributors 12.5 Aminoglycosides Antibiotics Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Aminoglycosides Antibiotics Industry Trends 13.2 Aminoglycosides Antibiotics Market Drivers 13.3 Aminoglycosides Antibiotics Market Challenges 13.4 Aminoglycosides Antibiotics Market Restraints 14 Key Findings in The Global Aminoglycosides Antibiotics Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Aminoglycosides Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Neomycin Table 3. Major Manufacturers of Tobramycin Table 4. Major Manufacturers of Gentamicin Table 5. Major Manufacturers of Amikacin Table 6. Major Manufacturers of Etimicin Table 7. Major Manufacturers of Others Table 8. Global Aminoglycosides Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 9. Global Aminoglycosides Antibiotics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 10. Global Aminoglycosides Antibiotics Sales by Region (2017-2022) & (M Units) Table 11. Global Aminoglycosides Antibiotics Sales Market Share by Region (2017-2022) Table 12. Global Aminoglycosides Antibiotics Sales by Region (2023-2028) & (M Units) Table 13. Global Aminoglycosides Antibiotics Sales Market Share by Region (2023-2028) Table 14. Global Aminoglycosides Antibiotics Revenue by Region (2017-2022) & (US$ Million) Table 15. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2017-2022) Table 16. Global Aminoglycosides Antibiotics Revenue by Region (2023-2028) & (US$ Million) Table 17. Global Aminoglycosides Antibiotics Revenue Market Share by Region (2023-2028) Table 18. Global Aminoglycosides Antibiotics Sales by Manufacturers (2017-2022) & (M Units) Table 19. Global Aminoglycosides Antibiotics Sales Share by Manufacturers (2017-2022) Table 20. Global Aminoglycosides Antibiotics Revenue by Manufacturers (2017-2022) & (US$ Million) Table 21. Global Aminoglycosides Antibiotics Revenue Share by Manufacturers (2017-2022) Table 22. Aminoglycosides Antibiotics Price by Manufacturers (2017-2022) &(USD/Unit) Table 23. Global Aminoglycosides Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI) Table 24. Global Aminoglycosides Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides Antibiotics as of 2021) Table 25. Aminoglycosides Antibiotics Manufacturing Base Distribution and Headquarters Table 26. Manufacturers Aminoglycosides Antibiotics Product Offered Table 27. Date of Manufacturers Enter into Aminoglycosides Antibiotics Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 30. Global Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 31. Global Aminoglycosides Antibiotics Sales Share by Type (2017-2022) Table 32. Global Aminoglycosides Antibiotics Sales Share by Type (2023-2028) Table 33. Global Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 34. Global Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 35. Global Aminoglycosides Antibiotics Revenue Share by Type (2017-2022) Table 36. Global Aminoglycosides Antibiotics Revenue Share by Type (2023-2028) Table 37. Aminoglycosides Antibiotics Price by Type (2017-2022) & (USD/Unit) Table 38. Global Aminoglycosides Antibiotics Price Forecast by Type (2023-2028) & (USD/Unit) Table 39. Global Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 40. Global Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 41. Global Aminoglycosides Antibiotics Sales Share by Application (2017-2022) Table 42. Global Aminoglycosides Antibiotics Sales Share by Application (2023-2028) Table 43. Global Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 44. Global Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 45. Global Aminoglycosides Antibiotics Revenue Share by Application (2017-2022) Table 46. Global Aminoglycosides Antibiotics Revenue Share by Application (2023-2028) Table 47. Aminoglycosides Antibiotics Price by Application (2017-2022) & (USD/Unit) Table 48. Global Aminoglycosides Antibiotics Price Forecast by Application (2023-2028) & (USD/Unit) Table 49. North America Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 50. North America Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 51. North America Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 52. North America Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 53. North America Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 54. North America Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 55. North America Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 56. North America Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 57. North America Aminoglycosides Antibiotics Sales by Country (2017-2022) & (M Units) Table 58. North America Aminoglycosides Antibiotics Sales by Country (2023-2028) & (M Units) Table 59. North America Aminoglycosides Antibiotics Revenue by Country (2017-2022) & (US$ Million) Table 60. North America Aminoglycosides Antibiotics Revenue by Country (2023-2028) & (US$ Million) Table 61. Europe Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 62. Europe Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 63. Europe Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 64. Europe Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 65. Europe Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 66. Europe Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 67. Europe Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 68. Europe Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 69. Europe Aminoglycosides Antibiotics Sales by Country (2017-2022) & (M Units) Table 70. Europe Aminoglycosides Antibiotics Sales by Country (2023-2028) & (M Units) Table 71. Europe Aminoglycosides Antibiotics Revenue by Country (2017-2022) & (US$ Million) Table 72. Europe Aminoglycosides Antibiotics Revenue by Country (2023-2028) & (US$ Million) Table 73. Asia Pacific Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 74. Asia Pacific Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 75. Asia Pacific Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 76. Asia Pacific Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 77. Asia Pacific Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 78. Asia Pacific Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 79. Asia Pacific Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 80. Asia Pacific Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 81. Asia Pacific Aminoglycosides Antibiotics Sales by Region (2017-2022) & (M Units) Table 82. Asia Pacific Aminoglycosides Antibiotics Sales by Region (2023-2028) & (M Units) Table 83. Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2017-2022) & (US$ Million) Table 84. Asia Pacific Aminoglycosides Antibiotics Revenue by Region (2023-2028) & (US$ Million) Table 85. Latin America Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 86. Latin America Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 87. Latin America Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 88. Latin America Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 89. Latin America Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 90. Latin America Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 91. Latin America Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 92. Latin America Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 93. Latin America Aminoglycosides Antibiotics Sales by Country (2017-2022) & (M Units) Table 94. Latin America Aminoglycosides Antibiotics Sales by Country (2023-2028) & (M Units) Table 95. Latin America Aminoglycosides Antibiotics Revenue by Country (2017-2022) & (US$ Million) Table 96. Latin America Aminoglycosides Antibiotics Revenue by Country (2023-2028) & (US$ Million) Table 97. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2017-2022) & (M Units) Table 98. Middle East and Africa Aminoglycosides Antibiotics Sales by Type (2023-2028) & (M Units) Table 99. Middle East and Africa Aminoglycosides Antibiotics Revenue by Type (2017-2022) & (US$ Million) Table 100. Middle East and Africa Aminoglycosides Antibiotics Revenue by Type (2023-2028) & (US$ Million) Table 101. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2017-2022) & (M Units) Table 102. Middle East and Africa Aminoglycosides Antibiotics Sales by Application (2023-2028) & (M Units) Table 103. Middle East and Africa Aminoglycosides Antibiotics Revenue by Application (2017-2022) & (US$ Million) Table 104. Middle East and Africa Aminoglycosides Antibiotics Revenue by Application (2023-2028) & (US$ Million) Table 105. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2017-2022) & (M Units) Table 106. Middle East and Africa Aminoglycosides Antibiotics Sales by Country (2023-2028) & (M Units) Table 107. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2017-2022) & (US$ Million) Table 108. Middle East and Africa Aminoglycosides Antibiotics Revenue by Country (2023-2028) & (US$ Million) Table 109. Jemicare Corporation Information Table 110. Jemicare Description and Major Businesses Table 111. Jemicare Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Jemicare Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 113. Jemicare Recent Developments Table 114. Teva Corporation Information Table 115. Teva Description and Major Businesses Table 116. Teva Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Teva Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 118. Teva Recent Developments Table 119. Novartis Corporation Information Table 120. Novartis Description and Major Businesses Table 121. Novartis Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Novartis Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 123. Novartis Recent Developments Table 124. Fangyuan-pharma Corporation Information Table 125. Fangyuan-pharma Description and Major Businesses Table 126. Fangyuan-pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Fangyuan-pharma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 128. Fangyuan-pharma Recent Developments Table 129. Aike Pharmaceutical Corporation Information Table 130. Aike Pharmaceutical Description and Major Businesses Table 131. Aike Pharmaceutical Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Aike Pharmaceutical Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 133. Aike Pharmaceutical Recent Developments Table 134. Cipla Corporation Information Table 135. Cipla Description and Major Businesses Table 136. Cipla Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 137. Cipla Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 138. Cipla Recent Developments Table 139. Pfizer Corporation Information Table 140. Pfizer Description and Major Businesses Table 141. Pfizer Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 142. Pfizer Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 143. Pfizer Recent Developments Table 144. Fresenius Kabi Corporation Information Table 145. Fresenius Kabi Description and Major Businesses Table 146. Fresenius Kabi Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 147. Fresenius Kabi Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 148. Fresenius Kabi Recent Developments Table 149. Sun Pharma Corporation Information Table 150. Sun Pharma Description and Major Businesses Table 151. Sun Pharma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 152. Sun Pharma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 153. Sun Pharma Recent Developments Table 154. Hikma Corporation Information Table 155. Hikma Description and Major Businesses Table 156. Hikma Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 157. Hikma Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 158. Hikma Recent Developments Table 159. Lannett Company Corporation Information Table 160. Lannett Company Description and Major Businesses Table 161. Lannett Company Aminoglycosides Antibiotics Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 162. Lannett Company Aminoglycosides Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications Table 163. Lannett Company Recent Developments Table 164. Key Raw Materials Lists Table 165. Raw Materials Key Suppliers Lists Table 166. Aminoglycosides Antibiotics Distributors List Table 167. Aminoglycosides Antibiotics Customers List Table 168. Aminoglycosides Antibiotics Market Trends Table 169. Aminoglycosides Antibiotics Market Drivers Table 170. Aminoglycosides Antibiotics Market Challenges Table 171. Aminoglycosides Antibiotics Market Restraints Table 172. Research Programs/Design for This Report Table 173. Key Data Information from Secondary Sources Table 174. Key Data Information from Primary Sources List of Figures Figure 1. Aminoglycosides Antibiotics Product Picture Figure 3. Global Aminoglycosides Antibiotics Market Share by Type in 2021 & 2028 Figure 3. Neomycin Product Picture Figure 4. Tobramycin Product Picture Figure 5. Gentamicin Product Picture Figure 6. Amikacin Product Picture Figure 7. Etimicin Product Picture Figure 8. Others Product Picture Figure 9. Global Aminoglycosides Antibiotics Market Share by Application in 2021 & 2028 Figure 10. Hospital Figure 11. Clinic Figure 12. Post Care Facility Figure 13. Government & Military Figure 14. Others Figure 15. Aminoglycosides Antibiotics Report Years Considered Figure 16. Global Aminoglycosides Antibiotics Sales 2017-2028 (M Units) Figure 17. Global Aminoglycosides Antibiotics Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 18. Global Aminoglycosides Antibiotics Revenue 2017-2028 (US$ Million) Figure 19. Global Aminoglycosides Antibiotics Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 20. Global Aminoglycosides Antibiotics Sales Market Share by Region (2017-2022) Figure 21. Global Aminoglycosides Antibiotics Sales Market Share by Region (2023-2028) Figure 22. North America Aminoglycosides Antibiotics Sales YoY (2017-2028) & (M Units) Figure 23. North America Aminoglycosides Antibiotics Revenue YoY (2017-2028) & (US$ Million) Figure 24. Europe Aminoglycosides Antibiotics Sales YoY (2017-2028) & (M Units) Figure 25. Europe Aminoglycosides Antibiotics Revenue YoY (2017-2028) & (US$ Million) Figure 26. Asia-Pacific Aminoglycosides Antibiotics Sales YoY (2017-2028) & (M Units) Figure 27. Asia-Pacific Aminoglycosides Antibiotics Revenue YoY (2017-2028) & (US$ Million) Figure 28. Latin America Aminoglycosides Antibiotics Sales YoY (2017-2028) & (M Units) Figure 29. Latin America Aminoglycosides Antibiotics Revenue YoY (2017-2028) & (US$ Million) Figure 30. Middle East & Africa Aminoglycosides Antibiotics Sales YoY (2017-2028) & (M Units) Figure 31. Middle East & Africa Aminoglycosides Antibiotics Revenue YoY (2017-2028) & (US$ Million) Figure 32. The Aminoglycosides Antibiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 33. The Top 5 and 10 Largest Manufacturers of Aminoglycosides Antibiotics in the World: Market Share by Aminoglycosides Antibiotics Revenue in 2021 Figure 34. Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 35. Global Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 36. Global Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 37. Global Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 38. Global Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 39. North America Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 40. North America Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 41. North America Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 42. North America Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 43. North America Aminoglycosides Antibiotics Sales Share by Country (2017-2028) Figure 44. North America Aminoglycosides Antibiotics Revenue Share by Country (2017-2028) Figure 45. U.S. Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 46. Canada Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 47. Europe Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 48. Europe Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 49. Europe Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 50. Europe Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 51. Europe Aminoglycosides Antibiotics Sales Share by Country (2017-2028) Figure 52. Europe Aminoglycosides Antibiotics Revenue Share by Country (2017-2028) Figure 53. Germany Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 54. France Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 55. U.K. Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 56. Italy Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 57. Russia Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 58. Asia Pacific Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 59. Asia Pacific Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 60. Asia Pacific Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 61. Asia Pacific Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 62. Asia Pacific Aminoglycosides Antibiotics Sales Share by Region (2017-2028) Figure 63. Asia Pacific Aminoglycosides Antibiotics Revenue Share by Region (2017-2028) Figure 64. China Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 65. Japan Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 66. South Korea Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 67. India Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 68. Australia Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 69. Taiwan Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 70. Indonesia Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 71. Thailand Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 72. Malaysia Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 73. Latin America Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 74. Latin America Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 75. Latin America Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 76. Latin America Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 77. Latin America Aminoglycosides Antibiotics Sales Share by Country (2017-2028) Figure 78. Latin America Aminoglycosides Antibiotics Revenue Share by Country (2017-2028) Figure 79. Mexico Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 80. Brazil Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 81. Argentina Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 82. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Type (2017-2028) Figure 83. Middle East and Africa Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2028) Figure 84. Middle East and Africa Aminoglycosides Antibiotics Sales Market Share by Application (2017-2028) Figure 85. Middle East and Africa Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2028) Figure 86. Middle East and Africa Aminoglycosides Antibiotics Sales Share by Country (2017-2028) Figure 87. Middle East and Africa Aminoglycosides Antibiotics Revenue Share by Country (2017-2028) Figure 88. Turkey Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 89. Saudi Arabia Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 90. UAE Aminoglycosides Antibiotics Revenue (2017-2028) & (US$ Million) Figure 91. Aminoglycosides Antibiotics Value Chain Figure 92. Aminoglycosides Antibiotics Production Process Figure 93. Channels of Distribution Figure 94. Distributors Profiles Figure 95. Bottom-up and Top-down Approaches for This Report Figure 96. Data Triangulation Figure 97. Key Executives Interviewed

Jemicare Teva Novartis Fangyuan-pharma Aike Pharmaceutical Cipla Pfizer Fresenius Kabi Sun Pharma Hikma Lannett Company